Close

Jazz Pharmaceuticals (JAZZ) Misses Q2 EPS by 17c; Issues Mixed Outlook

Go back to Jazz Pharmaceuticals (JAZZ) Misses Q2 EPS by 17c; Issues Mixed Outlook